STING agonist-12
|
STING AGONIST-12
|
2259624-71-8
|
JQAD1
|
化合物JQAD1
|
2417097-18-6
|
Matairesinoside
|
羅漢松脂苷
|
23202-85-9
|
2-MPPA
|
2-(3-sulfanylpropyl)pentanedioic acid
|
254737-29-6
|
MARK4 inhibitor 1
|
MARK4 inhibitor 1
|
2271081-58-2
|
M2N12
|
M2N12
|
2376577-06-7
|
G140
|
化合物G140
|
2369751-07-3
|
E64FC26
|
E64FC26
|
2285446-62-8
|
HWL-088
|
HWL-088
|
2378617-96-8
|
IHMT-PI3Kδ-372
|
化合物IHMT-PI3KΔ-372
|
2429889-62-1
|
IL-17 modulator 4
|
IL-17調(diào)節(jié)劑4
|
2446803-65-0
|
NF-κΒ activator 1
|
化合物NF-ΚΒ ACTIVATOR 1
|
2387524-59-4
|
BSJ-4-116
|
化合物BSJ-4-116
|
2519823-34-6
|
DHODH-IN-16
|
化合物DHODH-IN-16
|
2511248-11-4
|
KB-0742 dihydrochloride
|
KB-0742 dihydrochloride
|
2416874-75-2
|
Evifacotrep
|
依法曲普
|
2413739-88-3
|
EZM0414
|
EZM0414
|
2411748-50-8
|
ACSS2-IN-2
|
化合物ACSS2-IN-2
|
2332820-04-7
|
DDO-7263
|
化合物DDO-7263
|
2254004-96-9
|
Phenazine-1-carboxylic acid
|
申嗪霉素
|
2538-68-3
|
SM-360320
|
6-氨基-7,9-二氫-2-(2-甲氧基乙氧基)-9-(苯甲基)-8H-嘌呤-8-酮
|
226907-52-4
|
C16-Ceramide
|
N-棕櫚酰神經(jīng)鞘氨醇
|
24696-26-2
|
Bractoppin
|
Bractoppin
|
2290527-07-8
|
Maralixibat chloride
|
HP-625)
|
228113-66-4
|
JAK2/FLT3-IN-1
|
JAK2/FLT3-IN-1
|
2387765-27-5
|
SARS-CoV-2 Mpro-IN-9
|
Hispidulin 4'-O-β-D-glucopyranoside
|
244285-12-9
|
15-LOX-1 inhibitor 1
|
9C(I472)
|
2349374-37-2
|
Lufotrelvir
|
化合物PF-07304814
|
2468015-78-1
|
GSK778
|
GSK778
|
2451862-42-1
|
G6PDi-1
|
4-((5-氧代-6,7,8,9-四氫-5H-環(huán)庚并[D]嘧啶-2-基)氨基)噻吩-2-甲腈
|
2457232-14-1
|
XL177A
|
化合物XL177A
|
2417089-74-6
|
Camonsertib
|
(3-內(nèi))-3-[6-[(3R)-3-甲基-4-嗎啉基]-1-(1H-吡唑-3-基)-1H-吡唑并[3,4-B]吡啶-4-基]-8-氧雜雙環(huán)[3.2.1]辛-3-醇
|
2417489-10-0
|
BAY 2666605
|
化合物BAY 2666605
|
2275774-60-0
|
BRM/BRG1 ATP Inhibitor-2
|
化合物 BRM/BRG1 ATP INHIBITOR-2
|
2368900-77-8
|
Bruceine B
|
鴉膽子素B
|
25514-29-8
|
Terameprocol
|
EM-1421
|
24150-24-1
|
2-Phenylethyl isothiocyanate
|
2-苯基乙基異硫代氰酸酯
|
2257-09-2
|
WDR5-IN-1
|
WDR5-IN-1
|
2408842-51-1
|
HPK1-IN-7
|
1(3H)-Isobenzofuranone, 5-[[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-5-(1,3,4-oxadiazol-2-yl)-2-pyrimidinyl]amino]-3,3-dimethyl-
|
2320462-65-3
|
ASK1-IN-2
|
1H-Indole-2-carboxamide, 6-fluoro-N-[6-[4-(1-methylethyl)-4H-1,2,4-triazol-3-yl]-2-pyridinyl]-
|
2541792-70-3
|
dCBP-1
|
化合物DCBP-1
|
2484739-25-3
|
IL-17A inhibitor 1
|
化合物IL-17A INHIBITOR 1
|
2452464-73-0
|
BAY-3827
|
BAY-3827
|
2377576-35-5
|
CA77.1
|
化合物CA77.1
|
2412270-22-3
|
Polyinosinic-polycytidylic acid
|
聚肌苷-聚胞苷酸復合物
|
24939-03-5
|
Apostatin-1
|
Benzeneacetamide, N-cycloheptyl-α-[(4,5-dihydro-1-methyl-1H-imidazol-2-yl)thio]-
|
2559703-06-7
|
Adaphostin
|
化合物ADAPHOSTIN
|
241127-58-2
|
VULM 1457
|
VULM 1457
|
228544-65-8
|
Wiskostatin
|
WISKOSTATIN
|
253449-04-6
|
Evixapodlin
|
(5S,5'S)-5,5'-((((5,5'-(2,2'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis(3-methoxypyrazine-5,2-diyl))bis(methylene))bis(azanediyl))bis(methylene))bis(pyrrolidin-2-one)
|
2374856-75-2
|
JKE-1674
|
JKE-1674
|
2421119-60-8
|
Pratensein
|
紅車軸草素
|
2284-31-3
|
ATX inhibitor 5
|
ATX inhibitor 5
|
2402772-45-4
|
CU-115
|
化合物CU-115
|
2471982-20-2
|
PF-07220060
|
CDK4/6-IN-6
|
2380321-51-5
|
Tuspetinib
|
化合物HM43239
|
2294874-49-8
|
Elenestinib
|
化合物BLU-263
|
2505078-08-8
|
EB-42486
|
化合物EB-42486
|
2390475-81-5
|
GA-017
|
化合物GA-017
|
2351906-74-4
|
YS-370
|
化合物YS-370
|
2470908-79-1
|
Geranylgeraniol
|
香葉基香葉醇
|
24034-73-9
|
SU056
|
化合物SU056
|
2376580-08-2
|
ZX-29
|
ZX-29
|
2254805-62-2
|
GMB-475
|
GMB-475
|
2490599-18-1
|
(S)-Sunvozertinib
|
2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]-
|
2370013-49-1
|
TP0586532
|
TP0586532
|
2427584-96-9
|
Migoprotafib
|
抑制劑
|
2377352-49-1
|
Cyclothiazide
|
莰烯氯噻嗪
|
2259-96-3
|
Nampt-IN-5
|
化合物NAMPT-IN-5
|
2380013-17-0
|
Reverse transcriptase-IN-1
|
Reverse transcriptase-IN-1
|
2380001-43-2
|
JR14a
|
JR14a
|
2411440-41-8
|
RBN-3143
|
PARP14抑制劑
|
2360853-16-1
|
Djalonensone
|
交鏈孢霉甲基醚
|
23452-05-3
|
Sincalide
|
辛卡利特
|
25126-32-3
|
Anhydroerythromycin A
|
脫水紅霉素
|
23893-13-2
|
MAGL-IN-1
|
MAGL-IN-1
|
2324160-91-8
|
Enbezotinib
|
TPX-0046
|
2359649-81-1
|
FLT3-IN-4
|
FLT3-IN-4
|
2304799-09-3
|
AES-135
|
AES-135
|
2361659-61-0
|
MS31
|
MS31
|
2366264-12-0
|
PARP/PI3K-IN-1
|
CAY10749
|
2337386-47-5
|
PD-1/PD-L1-IN-NP19
|
化合物PD-1/PD-L1-IN-NP19
|
2377916-66-8
|
BSH-IN-1
|
BSH-IN-1
|
2553217-91-5
|
IHMT-MST1-58
|
化合物 IHMT-MST1-58
|
2414484-25-4
|
Monaschromone
|
苦楝萜酮內(nèi)酯
|
22611-36-5
|
ASK1-IN-1
|
N-(6-(4-異丙基-4H-1,2,4-三唑-3-基)吡啶-2-基)-3-甲氧基-1-(吡嗪-2-基)-1H-吡唑-4-甲酰胺
|
2411382-24-4
|
SY-5609
|
7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈
|
2417302-07-7
|
Zanzalintinib
|
XL092
|
2367004-54-2
|
IU1-248
|
Benzonitrile, 4-[3-[2-(4-hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl]-
|
2307472-03-1
|
Pumecitinib
|
化合物PUMECITINIB
|
2401057-12-1
|
PLN-1474
|
PLN1474
|
2408065-32-5
|
HS271
|
化合物HS271
|
2410393-15-4
|
Lirafugratinib
|
化合物FGFR2-IN-3
|
2549174-42-5
|
D-(+)-Cellobiose-
|
21-DEOXYCORTISOL
|
2479914-04-8
|
Menin-MLL inhibitor 20
|
Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester
|
2448173-47-3
|
Sovilnesib
|
化合物 SOVILNESIB
|
2410796-79-9
|
VU6015929
|
Benzamide, 4-fluoro-3-[[[5-(1-methyl-1H-pyrazol-3-yl)-3-pyridinyl]methyl]amino]-N-[3-(trifluoromethoxy)phenyl]-
|
2442597-56-8
|
Palmitic acid-
|
化合物NCT-58
|
2411429-33-7
|
SCR130
|
1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo-
|
2377858-38-1
|
GNF2133
|
4-乙基-N-(4-(1-(四氫-2H-吡喃-4-基)-1H-吡咯并[2,3-C]吡啶-3-基)吡啶-2-基)哌嗪-1-甲酰胺
|
2561414-56-8
|